Outcome
| Type |
Measure |
Description |
Time frame |
Safety issue |
| Primary |
Change CKD knowledge |
kidney disease knowledge will be measured using a self-report instrument Kidney Disease Knowledge Survey (KiKS). It includes 28 questions, 5 multiple choice type questions and 23 Yes-No questions; none of the questions included an "I don´t know" option. To assess the survey score, 1 point was given to each correct answer and zero to each wrong one. The questionnaire doesn't have domains, and the total score was calculated as the sum of the correct responses to each question divided by the total number of questions, which results in values from 0 to 1 where 1 means the highest level of knowledge. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Primary |
Change CKD Self-Management Behavior |
CKD self-management behavior will be assessed by Self-report instrument Chronic Kidney Disease Self-management (CKD-SM) by (C. C. Lin et al., 2013). CKD-SM instrument contains of 29-item to measure participants' self-management behavior factors. Each item is scored on a Likert scale from 1-4 with 1 being 'never' and 4 'always'. Total scores of the CKD-SM range from 29 to 116 and higher scores indicate better self-management behavior in managing CKD. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change Self-efficacy to manage CKD. |
Self-efficacy will be measured by using a self-report instrument the Stanford Self-Efficacy for Managing Chronic Disease - 6-item Scale. This widely used six-item instrument was derived from several self-efficacy scales developed and tested for the Chronic Disease Self-Management study by Lorig et al., 2001. Each item is scored on a 10-point Likert scale ranging from "not at all confident" (1) to "totally confident" (10), with a total score ranging from 6-60. The scale is scored by calculating the mean of at least four of the six items, therefore allowing for a maximum of two missing items. A higher number indicates a higher self-efficacy. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change Health-related quality of life (HRQoL): Malay KDQOL-36TM |
Health-related quality of life will be assessed using a self-report instrument Malay version of the Kidney Disease Quality of life (KDQOL-36TM) originally developed by RAND Health Organization, the University of Arizona for individuals with CKD and on dialysis. KDQOL-36TM consists of 12 items which measure physical functioning (physical component summary PCS) and mental functioning (mental component summary MCS), four items to assess the burden of kidney disease, 12 items for symptoms and problems, and eight items to measure the effects of kidney disease on daily life. The scores of the KDQOL-36TM are transformed into 0 to 100, with higher scores indicating better HRQoL. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change Systolic Blood Pressure |
Systolic Blood Pressure will be assessed using CARESCAPE DINAMAP technology digital blood pressure monitor model V100, BP assessor will obtain three BP measures in the right arm after the participant has been sitting quietly for 5 min. An average of the 3 measures is recorded. The recommended Systolic Blood Pressure lower of 130 mm Hg. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change 24-hour Urine Creatinine |
24-hour urine creatinine will assessed using Jaffe, rate blanking for 24 hour urine collection with (mmol/24Hr) units of measures. The reference range for Males:3.45-21 mmol/24h and for Females: 7-14 mmol/24h. Higher than 21 mmol/24h and higher thank 14 mmol/24h is not recommended for male and female respectively. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change 24-hour Urine Protein |
24-hour urine protein will assessed using Turbidimetric method Benzethonium chloride for 24 hour urine collection with (g/24Hr) units of measures. The reference range <0.14 g/24h. Higher than<0.14 g/24h is not recommended. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change 24-hour Urine Urea |
24-hour Urine Urea will assessed using Kinetic test with urease and glutamate dehydrogenase for 24 hour urine collection with (mmol/24Hr) units of measures. The reference range is 428-714 mmol/24h. Higher than 714 mmol/24h is not recommended. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change 24-hour Urine Sodium |
24-hour Urine Sodium will assessed using ISE indirect for 24 hour urine collection with (mmol/24Hr) units of measures.The reference range is 40-220 mmol/24hr. Higher than 220 mmol/24hr is not recommended. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change 24-hour Urine Potassium |
24-hour Urine Potassium will assessed using ISE indirect for 24 hour urine collection with (mmol/24Hr) units of measures. The reference range 25-125 mmol/24hr. Higher than 125 mmol/24hr is not recommended. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
| Secondary |
Change Diastolic Blood Pressure |
Diastolic Blood Pressure will be assessed using CARESCAPE DINAMAP technology digital blood pressure monitor model V100, BP assessor will obtain three BP measures in the right arm after the participant has been sitting quietly for 5 min. An average of the 3 measures is recorded.The recommended Diastolic Blood Pressure lower of 80 mm Hg. |
Timepoint 1 = Baseline. Repeated measurement: Timepoint 2 = week 12 (Five week post-intervention) |
|
